Track Medtech Start-ups

Learn More
innovation hub

BioAssets Development Corporation (aka BDC) (Acquired) is Profiled in this Database

Updated At 25 Oct, 2011

Start Free 7 Day Trial Now
Partial description of this company
Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioAssets Development Corporation (aka BDC) (Acquired) plus 4781 other startups.

Start Free 7 Day Trial Now

Learn More About BioAssets Development Corporation (aka BDC) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Our Clients